Literature DB >> 21157733

[Factors that affect time delays to fibrinolytic treatment in ischaemic stroke].

Alfredo Palomino-García1, Francisco Moniche-Álvarez, Francisco J de la Torre-Laviana, Aurelio Cayuela-Domínguez, Eduardo Vigil, M Dolores Jiménez-Hernández.   

Abstract

INTRODUCTION: Extending the thrombolytic therapy window in ischaemic stroke to 4.5 hours has proved to be useful and safe, but a prompt response remains a decisive factor. AIM: To analyse the factors that delay treatment. PATIENTS AND METHODS: After activating the Stroke Code procedure, the consecutive cases of stroke attended in the emergency department throughout the year 2006 were recorded; data included their clinical and epidemiological features, origin, means of transport and delay times in the process.
RESULTS: Of the total number of patients with ischaemic stroke, 10.1% finished the emergency study with a median of 1 hour to decide to carry out treatment within 3 hours, and 13.1% of them between 3 and 4.5 hours, with a median of 2 hours and 6 minutes. For the analysis of all the variables, 498 patients were selected; 39% were admitted to hospital within the first 3 hours and 11.2% between 3 and 4.5 hours of the onset of symptoms. The use of the emergency telephone system, transport by mobile ICU or ambulance and an impaired level of consciousness, sight or, to a lesser extent, language or speech were related to shorter delay times.
CONCLUSIONS: The factors that depended on the actual patient, in general, did not shorten the delay time. Clinical severity, the presence of informants and activating the emergency system shortened intervention times.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157733

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  1 in total

1.  Development, Implementation, and Evaluation of a Telemedicine Service for the Treatment of Acute Stroke Patients: TeleStroke.

Authors:  Carlos Parra; Francisco Jódar-Sánchez; M Dolores Jiménez-Hernández; Eduardo Vigil; Alfredo Palomino-García; Francisco Moniche-Álvarez; Francisco Javier De la Torre-Laviana; Patricia Bonachela; Francisco José Fernández; Aurelio Cayuela-Domínguez; Sandra Leal
Journal:  Interact J Med Res       Date:  2012-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.